Company: VREOF
Filing Date: 2025-03-07
Form Type: PRE 14C
Source: 0001140361-25-007601
Chunk: 363

Company: Vireo Growth Inc.
Filing Date: 2025-03-07
Form: PRE 14C
Chunk 363
---
 unamortized debt discount       |     |   -441,461 |     |    -602,255 |
|                                      |     | $5,578,273 |     |  $8,942,262 |

Future maturities of long-term debt are as follows:

| Years Ending December 31, |     |            |
| 2025                      |     | $3,536,763 |
| 2026                      |     |  3,905,748 |
| 2027                      |     |  2,257,568 |
| Total                     |     | $9,700,079 |

7. Stockholders’ Equity Common Stock The Company has authorized the issuance of 20,385,567 shares of common stock. Outstanding shares as of December 31, 2024 and 2023 were 17,300,542 and 17,157,342 respectively. The Company’s common stock entitles holders to one vote for each share on all matters submitted to a vote of the shareholders. Holders of common stock do not have any cumulative voting rights. In the event of the Company’s liquidation or dissolution, holders of the Series A Common Stock are entitled to share ratably in all assets remaining after payment of all debts and other liabilities, subject to the prior rights of any outstanding Series B Common Stock. Holders of the common stock have no dividend, preemptive, subscription, redemption or conversion rights. Common Stock Warrants The Company has entered into warrant agreements in connection with credit agreements and promissory notes (see Notes 5 and 6). The Company has issued an aggregate 3,516,973 warrants. Prior to 2022, 1,974,701 warrants were exercised at their exercise price of $0.01. No warrants were exercised in 2023 or 2024. Arches Series 2 Preferred Stock Embedded Conversion Feature During 2024, Arches issued 2,273,362 shares of Series 2 preferred stock to a noncontrolling interest investor in exchange for $1,400,000. The Series 2 preferred stock has an embedded conversion that allows the holder of the Series 2 preferred stock to convert to common stock. The Series 2 preferred stock had an original issue price of $0.61528. If the holder of the Series 2 preferred stock achieves certain accretive market share revenue as defined in the operating agreement from use of the Arches software platform the conversion price will ratchet down to